cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.13218563
title: Ntrk_G667S_Act_Foretinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218560
title: Ntrk_G667S_Act_Entrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218599
title: Ntrk_G667C_Act_Altiratinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218557.v1
title: Ntrk_G667S_Inact_Altiratinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218557
title: Ntrk_G667S_Inact_Altiratinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218572.v1
title: Ntrk_G667S_Inact_Larotrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218602.v1
title: Ntrk_G667C_Inact_Lacrotrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218566.v1
title: Ntrk_G667S_Act_Larotrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218560.v1
title: Ntrk_G667S_Act_Entrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218569.v1
title: Ntrk_G667S_Act_Altiratinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218572
title: Ntrk_G667S_Inact_Larotrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218593
title: Ntrk_G667C_Act_Lacrotrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218554
title: Ntrk_G667S_Inact_Foretinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218566
title: Ntrk_G667S_Act_Larotrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218545.v1
title: Ntrk_G667S_Inact_Entrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218563.v1
title: Ntrk_G667S_Act_Foretinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218569
title: Ntrk_G667S_Act_Altiratinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218554.v1
title: Ntrk_G667S_Inact_Foretinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218533.v1
title: Ntrk_V573M_Act_Entrectinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218533
title: Ntrk_V573M_Act_Entrectinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218473.v1
title: Wildtype NTRK1 (TrkA) kinase domain - inhibitor docking dataNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Raw data that support Table 1 in Somwar et al. (2020) Communication Biology publication.Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218536
title: Ntrk_V573M_Act_Altiratinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218473
title: Wildtype NTRK1 (TrkA) kinase domain - inhibitor docking dataNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Raw data that support Table 1 in Somwar et al. (2020) Communication Biology publication.Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218536.v1
title: Ntrk_V573M_Act_Altiratinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218509
title: Ntrk_V573M_Inact_Altiratinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218509.v2
title: Ntrk_V573M_Inact_Altiratinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218509.v1
title: Ntrk_V573M_Inact_Altiratinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218491.v1
title: Ntrk_Act_Cabozatinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.21227/xj65-4921
title: UTLN-Reflection

description: Existing datasets for reflection symmetry detection contain shapes which are single contour shapes, thus they are not really challenging. We also need to consider how well a symmetry detector works on complex/compound shapes where traditional methods based on contour approach can not. On the other hand, there is only one symmetrical axes for every shape of this dataset. Therefore, this fails to evaluate how a symmetry detector works on a shape containing several symmetrical axis and how good the detection is when the number of symmetrical axis is unknown. In order to address those above shortcomings, we introduce in this paper a new dataset, called ``UTLN Reflection dataset'', designed for evaluation of reflectional symmetry detection. The dataset, which is created by collecting free images on the Internet, contains two test suites: SRA (Single Reflection Axis) and MRA (Multiple Reflection Axes).
DOI: 10.21227/s4rk-sk11
title: UTLN-Reflection

description: Existing datasets for reflection symmetry detection contain shapes which are single contour shapes, thus they are not really challenging. We also need to consider how well a symmetry detector works on complex/compound shapes where traditional methods based on contour approach can not. On the other hand, there is only one symmetrical axes for every shape of this dataset. Therefore, this fails to evaluate how a symmetry detector works on a shape containing several symmetrical axis and how good the detection is when the number of symmetrical axis is unknown. In order to address those above shortcomings, we introduce in this paper a new dataset, called ``UTLN Reflection dataset'', designed for evaluation of reflectional symmetry detection. The dataset, which is created by collecting free images on the Internet, contains two test suites: SRA (Single Reflection Axis) and MRA (Multiple Reflection Axes).
DOI: 10.6084/m9.figshare.13218467.v1
title: Ntrk_Inact_Cabozatinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218527
title: Ntrk_V573M_Inact_Larotrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218527.v1
title: Ntrk_V573M_Inact_Larotrectinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218530.v1
title: Ntrk_V573M_Act_Cabozitinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218530
title: Ntrk_V573M_Act_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218530.v3
title: Ntrk_V573M_Act_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218530.v2
title: Ntrk_V573M_Act_Cabozitinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218491
title: Ntrk_Act_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutantsType I (active conformation of TrkA) docked with cabozantinib
DOI: 10.6084/m9.figshare.13218491.v3
title: Ntrk_Act_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutantsType I (active conformation of TrkA) docked with cabozantinib
DOI: 10.6084/m9.figshare.13218491.v2
title: Ntrk_Act_Cabozatinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218485
title: Ntrk_Act_Foretinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutantsType I (active conformation of TrkA) docked with foretinib<br>
DOI: 10.6084/m9.figshare.13218485.v2
title: Ntrk_Act_Foretinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutantsType I (active conformation of TrkA) docked with foretinib<br>
DOI: 10.6084/m9.figshare.13218485.v1
title: Ntrk_Act_Foretinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218488
title: Ntrk_Act_Altiratinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutantsType I (active conformation of TrkA) docked with altiratinib<br>
DOI: 10.6084/m9.figshare.13218488.v1
title: Ntrk_Act_Altiratinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218482
title: Ntrk_Act_Entrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutantsType I (active conformation of TrkA) docked with entrectinib<br>
DOI: 10.6084/m9.figshare.13218482.v1
title: Ntrk_Act_Entrectinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218479
title: Ntrk_Inact_Entrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutantsType II (inactive conformation of TrkA) docked with entrectinib<br>
DOI: 10.6084/m9.figshare.13218479.v2
title: Ntrk_Inact_Entrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutantsType II (inactive conformation of TrkA) docked with entrectinib<br>
DOI: 10.6084/m9.figshare.13218479.v1
title: Ntrk_Inact_Entrectinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218476
title: Ntrk_Inact_Foretinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutantsType II (inactive conformation of TrkA) docked with foretinib<br>
DOI: 10.6084/m9.figshare.13218476.v1
title: Ntrk_Inact_Foretinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218470
title: Ntrk_Inact_Altiratinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutantsType II (inactive conformation of TrkA) docked with altiratinib<br>
DOI: 10.6084/m9.figshare.13218470.v1
title: Ntrk_Inact_Altiratinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218467
title: Ntrk_Inact_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutantsType II (inactive conformation of TrkA) docked with cabozantinib<br>
DOI: 10.6084/m9.figshare.13218467.v3
title: Ntrk_Inact_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutantsType II (inactive conformation of TrkA) docked with cabozantinib<br>
DOI: 10.6084/m9.figshare.13218467.v2
title: Ntrk_Inact_Cabozatinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13224620
title: TA_data.dta

description: Result of field experiment randomizing a peer review program among Teaching Assistants within the Economics Department at a large public university.
DOI: 10.6084/m9.figshare.13224620.v2
title: TA_data.dta

description: Result of field experiment randomizing a peer review program among Teaching Assistants within the Economics Department at a large public university.
DOI: 10.6084/m9.figshare.13224620.v1
title: TA_data.dta

description: Result of field experiment randomizing a peer review program among Teaching Assistants within the Economics Department at a large public university.
DOI: 10.6084/m9.figshare.13218464
title: Ntrk_Inact_Larotrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutantsType II (inactive conformation of TrkA) docked with larotrectinib<br>
DOI: 10.6084/m9.figshare.13218464.v2
title: Ntrk_Inact_Larotrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutantsType II (inactive conformation of TrkA) docked with larotrectinib<br>
DOI: 10.6084/m9.figshare.13218464.v1
title: Ntrk_Inact_Larotrectinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218521
title: Ntrk_V573M_Act_Larotrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218521.v2
title: Ntrk_V573M_Act_Larotrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218521.v1
title: Ntrk_V573M_Act_Larotrectinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218518
title: Ntrk_V573M_Inact_Entrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218518.v2
title: Ntrk_V573M_Inact_Entrectinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218518.v1
title: Ntrk_V573M_Inact_Entrectinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218515
title: Ntrk_V573M_Inact_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218515.v2
title: Ntrk_V573M_Inact_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218515.v1
title: Ntrk_V573M_Inact_Cabozitinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218512
title: Ntrk_V573M_Inact_Foretinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218512.v2
title: Ntrk_V573M_Inact_Foretinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218512.v1
title: Ntrk_V573M_Inact_Foretinib.logNTRK1 (TrkA) wildtype and mutant kinase domain - inhibitor docking studies

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218551
title: Ntrk_G667S_Act_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218551.v2
title: Ntrk_G667S_Act_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218551.v1
title: Ntrk_G667S_Act_Cabozatinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218548
title: Ntrk_G667S_Inact_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218548.v2
title: Ntrk_G667S_Inact_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218548.v1
title: Ntrk_G667S_Inact_Cabozatinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218596
title: Ntrk_G667C_Act_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218596.v2
title: Ntrk_G667C_Act_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218596.v1
title: Ntrk_G667C_Act_Cabozatinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218578
title: Ntrk_G667C_Inact_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218578.v2
title: Ntrk_G667C_Inact_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218578.v1
title: Ntrk_G667C_Inact_Cabozatinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218626
title: Ntrk_F589L_Act_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218626.v2
title: Ntrk_F589L_Act_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218626.v1
title: Ntrk_F589L_Act_Cabozatinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218623
title: Ntrk_F589L_Inact_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218623.v2
title: Ntrk_F589L_Inact_Cabozantinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.13218623.v1
title: Ntrk_F589L_Inact_Cabozatinib.log

description: Docking data for NTRK1 (TrkA) wildtype and mutants
DOI: 10.6084/m9.figshare.8055554
title: Effects of intradialytic resistance training on physical activity in daily life, muscle strength, physical capacity and quality of life in hemodialysis patients: a randomized clinical trial

description: <b>Purpose:</b> We evaluated the effects of supervised intradialytic resistance training on physical activity in daily life (PADL), muscle strength, physical capacity and quality of life (QoL) in hemodialysis patients. <b>Methods:</b> Twenty-four hemodialysis patients were randomly assigned to either a 12-weeks moderate-intensity resistance training or a control period. An accelerometer evaluated PADL for seven consecutive days, measuring the time spent in different activities and positions of daily routine and the number of steps taken. Muscle strength, physical capacity and QoL were evaluated. <b>Results:</b> After 12 weeks of training, we did not find significant difference (post-pre values) in walking time (−1.2 ± 18.3 vs. −9.2 ± 13.1 min/day); standing time (−10.2 ± 28.6 vs. 3.2 ± 20.1 min/day); sitting time (20.8 ± 58.9 vs. −30.0 ± 53.0 min/day); lying down time (−9.3 ± 57.9 vs. 34.6 ± 54.0 min/day); number of steps taken [−147 (1834) vs. −454 (2066)] and muscle strength in training and control group, respectively. There was a significant increase in the six-minute walking test distance (48.8 ± 35.9 vs. 6.9 ± 45.9 m, <i>p</i> <b>Conclusions:</b> PADL was not modified after 12 weeks of intradialytic resistance training in hemodialysis patients. However, the exercise program was able to increase the physical capacity and some domains of QoL.Implications for rehabilitationPhysical activity in daily life was not modified after 12 weeks of intradialytic resistance training in hemodialysis patients.The exercise program was able to increase the physical capacity, efficacy of dialysis and some domains of quality of life in hemodialysis patients.The protocol used in this study was safe since no complications were observed during and after resistance training.These results should be interpreted with caution because we applied a moderate resistance training in both lower limbs and in the contralateral arteriovenous fistula upper limb, using perceived exertion by Borg scale to exercise prescription. Moreover, the safety protocol evaluation was not conducted. Physical activity in daily life was not modified after 12 weeks of intradialytic resistance training in hemodialysis patients. The exercise program was able to increase the physical capacity, efficacy of dialysis and some domains of quality of life in hemodialysis patients. The protocol used in this study was safe since no complications were observed during and after resistance training. These results should be interpreted with caution because we applied a moderate resistance training in both lower limbs and in the contralateral arteriovenous fistula upper limb, using perceived exertion by Borg scale to exercise prescription. Moreover, the safety protocol evaluation was not conducted.
DOI: 10.6084/m9.figshare.8055554.v2
title: Effects of intradialytic resistance training on physical activity in daily life, muscle strength, physical capacity and quality of life in hemodialysis patients: a randomized clinical trial

description: <b>Purpose:</b> We evaluated the effects of supervised intradialytic resistance training on physical activity in daily life (PADL), muscle strength, physical capacity and quality of life (QoL) in hemodialysis patients. <b>Methods:</b> Twenty-four hemodialysis patients were randomly assigned to either a 12-weeks moderate-intensity resistance training or a control period. An accelerometer evaluated PADL for seven consecutive days, measuring the time spent in different activities and positions of daily routine and the number of steps taken. Muscle strength, physical capacity and QoL were evaluated. <b>Results:</b> After 12 weeks of training, we did not find significant difference (post-pre values) in walking time (−1.2 ± 18.3 vs. −9.2 ± 13.1 min/day); standing time (−10.2 ± 28.6 vs. 3.2 ± 20.1 min/day); sitting time (20.8 ± 58.9 vs. −30.0 ± 53.0 min/day); lying down time (−9.3 ± 57.9 vs. 34.6 ± 54.0 min/day); number of steps taken [−147 (1834) vs. −454 (2066)] and muscle strength in training and control group, respectively. There was a significant increase in the six-minute walking test distance (48.8 ± 35.9 vs. 6.9 ± 45.9 m, <i>p</i> <b>Conclusions:</b> PADL was not modified after 12 weeks of intradialytic resistance training in hemodialysis patients. However, the exercise program was able to increase the physical capacity and some domains of QoL.Implications for rehabilitationPhysical activity in daily life was not modified after 12 weeks of intradialytic resistance training in hemodialysis patients.The exercise program was able to increase the physical capacity, efficacy of dialysis and some domains of quality of life in hemodialysis patients.The protocol used in this study was safe since no complications were observed during and after resistance training.These results should be interpreted with caution because we applied a moderate resistance training in both lower limbs and in the contralateral arteriovenous fistula upper limb, using perceived exertion by Borg scale to exercise prescription. Moreover, the safety protocol evaluation was not conducted. Physical activity in daily life was not modified after 12 weeks of intradialytic resistance training in hemodialysis patients. The exercise program was able to increase the physical capacity, efficacy of dialysis and some domains of quality of life in hemodialysis patients. The protocol used in this study was safe since no complications were observed during and after resistance training. These results should be interpreted with caution because we applied a moderate resistance training in both lower limbs and in the contralateral arteriovenous fistula upper limb, using perceived exertion by Borg scale to exercise prescription. Moreover, the safety protocol evaluation was not conducted.